Actualización en el manejo terapéutico de la esofagitis eosinofílica en adultos

Abstract

Introduction: In recent years, eosinophilic esophagitis has emerged as one of the main causes of chronic gastrointestinal morbidity. Despite its low prevalence, there has been a steady increase in incidence, secondary to new lifestyle changes. Currently, there are established treatment protocols, hence it's crucial to be aware of the latest updates for the well-being of patients. Methodology: This is a narrative bibliographic review study, a broad literature review, about the update in the therapeutic management of eosinophilic esophagitis in adults, such as Pub Med, Scielo, Cochrane Library, and Science Direct, as part of the PRISMA strategy. Results: 57 studies were reviewed, which compiled the main recommendations on the update in the therapeutic management of eosinophilic esophagitis in adults. Conclusions: Eosinophilic esophagitis is a chronic disease secondary to an immune dysregulation process, whose incidence is increasing and its management should be comprehensive and be made up of pathologists, allergists, and nutrition specialists. This should be suspected in any patient with symptoms of refractory GERD or with dysphagia to solids or liquids, especially in young atopic males, besides clinical suspicion alone is an indication for a prompt endoscopic study and biopsy, even in a patient with a normal-looking esophagus.